What is it for stroke? Antidepressants improve stroke recovery. Is your doctor giving you all the information needed to make the best choices for your recovery?
https://www.alphagalileo.org/ViewItem.aspx?ItemId=184127&CultureCode=en
More research needed to identify reasons for higher mortality
Heart attack patients prescribed antidepressants have lower one-year
survival rates, according to research presented today at Acute
Cardiovascular Care 2018, a European Society of Cardiology congress.1
The observational study of nearly 9,000 patients found that those
prescribed antidepressants at discharge from hospital after a heart
attack had a 66% greater risk of mortality one year later than patients
not prescribed the drugs, although they noted the cause is not
necessarily related directly to the antidepressants.
Lead author Ms Nadia Fehr, a medical student at the University of
Zurich, Switzerland, said: “Previous studies have suggested that
cardiovascular disease may increase the likelihood of being depressed.
On the other hand, depression appears to increase the probability of
developing cardiovascular risk factors. However, little is known about
the impact of depression on outcome after a heart attack.”
This study assessed the association of antidepressant prescription at
hospital discharge with the one-year outcomes of patients with acute
myocardial infarction (heart attack).
Data from AMIS Plus, the Swiss nationwide registry for acute
myocardial infarction, were used to analyse 8,911 heart attack patients
admitted to hospitals in Switzerland between March 2005 and August 2016.
Patients were followed up by telephone 12 months after discharge.
The researchers compared patients who received antidepressant
medication at discharge with those who did not with regard to baseline
characteristics and one-year outcomes including mortality, a subsequent
heart attack, and stroke.
A total of 565 (6.3%) patients received antidepressants at discharge
from hospital. Compared to those who did not receive the drugs, patients
prescribed antidepressants were predominantly female, older, and more
likely to have hypertension, diabetes, dyslipidaemia, obesity and
comorbidities. They were less likely to undergo percutaneous coronary
intervention or receive P2Y12 blockers or statins, and stayed in
hospital longer.
After adjusting for baseline characteristics the researchers found
that the rates of stroke and subsequent heart attacks were similar
between the two groups, but patients prescribed antidepressants had
significantly worse survival. The rate of all-cause mortality at
one-year after discharge was 7.4% in patients prescribed antidepressants
compared to 3.4% for those not prescribed antidepressants (p<0.001).
Antidepressant prescription was an independent predictor for
mortality, and increased the odds by 66% (odds ratio: 1.66; 95%
confidence interval: 1.16 to 2.39).
“This was an observational study so we cannot conclude that antidepressants caused the higher death rate,” noted Ms Fehr.
She concluded: “Our study showed that many patients are treated with
antidepressants after a heart attack. More research is needed to
pinpoint the causes and underlying pathological mechanisms for the
higher mortality we observed in this patient group.”